DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 189 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $58,221,000 | +43.1% | 1,560,057 | -2.0% | 0.07% | +34.0% |
Q1 2021 | $40,696,000 | +34.7% | 1,591,568 | +16.1% | 0.05% | +32.5% |
Q4 2020 | $30,209,000 | +58.6% | 1,371,272 | +29.6% | 0.04% | +42.9% |
Q3 2020 | $19,042,000 | +3.4% | 1,058,455 | +46.0% | 0.03% | -6.7% |
Q2 2020 | $18,415,000 | – | 725,003 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |